muparfostat (PI-88) - Medigen Biotech
Progen: Annual Report 2015 (Progen) - Oct 30, 2015 - Anticipated expiry of patent for preparation and use of sulfated oligosaccharides in 2016 in Australia, Canada, China, European Union, Israel, Japan, Korea, Mexico, New Zealand, Poland, Singapore, South Africa, Taiwan, US and Brazil  
Anticipated patent expiry Oncology
http://www.progen-pharma.com/UserFiles/files/News/PGL%20AR2015%20web%20ready.pdf
 
Oct 30, 2015
 
.